Cargando…
Where is the limit of prostate cancer biomarker research? Systematic investigation of potential prognostic and diagnostic biomarkers
BACKGROUND: The identification of appropriate biomarkers is essential to support important clinical decisions in patients with prostate cancer. The aim of our study was a systematic bioinformatical analysis of the mRNA expression of all genes available for the prostate adenocarcinoma cohort of The C...
Autores principales: | Kremer, Anika, Kremer, Tobias, Kristiansen, Glen, Tolkach, Yuri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554887/ https://www.ncbi.nlm.nih.gov/pubmed/31170942 http://dx.doi.org/10.1186/s12894-019-0479-z |
Ejemplares similares
-
Prostate-specific membrane antigen expression in hepatocellular carcinoma: potential use for prognosis and diagnostic imaging
por: Tolkach, Yuri, et al.
Publicado: (2019) -
Adipophilin as prognostic biomarker in clear cell renal cell carcinoma
por: Tolkach, Yuri, et al.
Publicado: (2017) -
Prognostic role of TSPAN1, KIAA1324 and ESRP1 in prostate cancer
por: Stinnesbeck, Melissa, et al.
Publicado: (2021) -
Sensitivity of HOXB13 as a Diagnostic Immunohistochemical Marker of Prostatic Origin in Prostate Cancer Metastases: Comparison to PSA, Prostein, Androgen Receptor, ERG, NKX3.1, PSAP, and PSMA
por: Kristiansen, Ilka, et al.
Publicado: (2017) -
Serum miR-122-5p and miR-206 expression: non-invasive prognostic biomarkers for renal cell carcinoma
por: Heinemann, Frauke G., et al.
Publicado: (2018)